An open-label trial of aripiprazole in children and adolescents with bipolar disorder

Trial Profile

An open-label trial of aripiprazole in children and adolescents with bipolar disorder

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Jun 2013

At a glance

  • Drugs Aripiprazole (Primary)
  • Indications Bipolar I disorders
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 13 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Feb 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
    • 18 Dec 2007 The expected completion date for this trial is 1 Jul 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top